Katalin Ferencz-Biro

Title: Katalin Ferencz-Biro: Innovator in Alpha Interferon Research

Introduction

Katalin Ferencz-Biro is a notable inventor based in North Brunswick, NJ (US). She has made significant contributions to the field of antiviral research, particularly through her work on alpha interferon compositions. With a total of two patents to her name, her innovations are aimed at enhancing therapeutic options for viral infections.

Latest Patents

Katalin's latest patents include a composition containing human alpha interferon species proteins. This invention provides alpha interferon compositions that comprise one or a mixture of selected highly antiviral interferon proteins, characterized by increased anti-viral activity. These compositions may be used therapeutically in the treatment of viral infections, particularly retroviral or hepatitis infections, or as additives to conventional antiviral agents to increase their antiviral potency. Another patent focuses on the alpha interferon composition and method for its production from human sources.

Career Highlights

Katalin Ferencz-Biro has established herself as a key figure in the field of antiviral research. Her work at Interferon Sciences, Inc. has allowed her to explore innovative solutions to combat viral infections. Her research has the potential to significantly impact the treatment landscape for patients suffering from various viral diseases.

Collaborations

Some of her notable coworkers include Douglas Testa and Mei-June Liao, who contribute to the collaborative efforts in advancing antiviral research.

Conclusion

Katalin Ferencz-Biro's contributions to the field of antiviral research through her patents on alpha interferon compositions highlight her innovative spirit and dedication to improving therapeutic options for viral infections. Her work continues to pave the way for advancements in medical treatments.